Biological immunotherapy for intestinal tumors

Intestinal tumor biological immunotherapy can be used after intestinal tumor surgery, radiotherapy, chemotherapy, and the interval between chemotherapy courses. Immunotherapy can improve the patient's immune function and disease resistance, which is very beneficial to the relief of the disease and can significantly enhance the efficacy.

Common methods of biological immunotherapy for intestinal tumors:

1. Interferon (IFN) 1×106~3×106IU each time, once a day or 3 times a week, subcutaneously or intramuscularly. The dose can be gradually increased as appropriate. The maximum dose within 3 days can reach 2.4×108IU.

2. Tumor necrosis factor (TNF) is injected intramuscularly at a dose of 1 million U each time, for 3 consecutive days and 4 days off as a course of treatment. Depending on the patient's condition, it can be used for 3 to 5 courses of treatment. If used in combination with 1L-2 or interferon, it has a better therapeutic effect.

3.1L-2 is injected locally into the tumor. The general dose is 104~106IU each time, once every 2~3 days. Depending on the condition and side effects, 3~20 times can be a course of treatment.

4. Thymosin 2~10mg each time, intramuscular injection, once a day or every other day. Note that when using this drug, a skin test must be performed before injection or after stopping the drug.

Nowadays, biological immunotherapy for intestinal tumors is receiving more and more attention in medicine, and it also has certain development prospects in the treatment of intestinal tumors.

Intestinal tumors: http://www..com.cn/zhongliu/ca/czl.html